<DOC>
	<DOCNO>NCT00844272</DOCNO>
	<brief_summary>Study objective : Feasibility efficacy standardise psychosocial intervention ( psychoeducation ) substitute opioid dependent patient</brief_summary>
	<brief_title>Psychoeducation Reaches HCV-infected Methadone/Buprenorphine Substituted Patients Standard Antiviral Treatment</brief_title>
	<detailed_description>Primary objective : - Retention antiviral treatment ( feasibility ) Secondary objective : - Mental Health Mental health monitor mean Symptom Checklist 90-R ( SCL-90-R ) . Its sum score , Global Severity Index ( GSI ) , serve indicator . Mental health regard stable case change le 6 GSI-points , otherwise mental health regard improve ( GSI - 6 point ) decrease ( GSI + 6 point ) . - Course Addiction Course addiction antiviral treatment monitor accord retention substitution treatment , compliance schedule visit , co-consumption illicit drug ( patient record , urinalysis ) . - Sustained viral response ( SVR ) SVR measure polymerase chain reaction 6 month per protocol antiviral treatment ( ITT-analysis ) .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Substance Abuse , Intravenous</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>Women men age 18 70 year Opiate dependence accord ICD10 Stable substitution ( i.e . either keep last 5 date fulfil criterion Take Home assignment ) Proof HCV mean PCR Patient must therapy naive regard hepatitis C ( precede treatment attempt interferon and/or Ribavirin ) Ability comprehend und follow study protocol Compensated liver disease follow haematological biochemical minimum criterion : 1 . Leukocytes ≥ 3.000/mm3 2 . Neutrophile granulocytes ≥ 1.500/mm3 3 . Thrombocytes ≥ 90.000/mm3 4 . Direct indirect bilirubin within standard range ( factor , hepatitisconditioned , M. Meulengracht , represent explanation increase indirect bilirubin ; case indirect bilirubin must less 3.0 mg/dl 51.3 µmol/l ) 5 . Albumin within standard range 6 . Creatinine within standard range TSH ( Thyreotropine ) within standard range test laboratory Normal blood sugar value nondiabetics haemoglobin A1c max . 8.5 % diabetic ( induced pharmacotherapy and/or diet control ) . An eye examination require diabetic . Haemoglobin value ≥ 12 mg/dl woman and/or ≥ 13 mg/dl men ANA ≤ 1:160 In patient cirrhosis transition cirrhosis : exclusion hepatocellular carcinoma Readiness abstain alcohol interferon treatment . Negative pregnancy test female patient within 24 hour first dose Regular confirmation sexual active woman age capable childbearing and/or sexual active men use two reliable method contraception interferon / ribavirin treatment six month thereafter , one contraception method barrier effect ( e.g . condom , diaphragm ) Female patient may breastfeed interferon / ribavirin treatment . Decompensated liver cirrhosis ( ChildPugh B C ) Haemochromatosis Lack Alfa1Antitrypsin ( homozygote PIZZ ) MorbusWilson positive proof HBsAg , anti HIV anti HAV IgM antibodies Autoimmune disease ( e.g . autoimmune hepatitis , autoimmune thyroid disease , rheumatoid arthritis ) Kidney failure ( Creatinine &gt; 1,5 mg/dl ) Liver kidneytransplantation Hyperlipidemia ( Cholesterol &gt; 1,5times upper standard value ) Clinically manifest gout Severe heart insufficiency Severe coronary heart disease Patients cardiac pacemaker Severe chronic pulmonary disease ( e.g . COPD ) Serious psychological illness , particular severe depression Epilepsy Oesophagus varicose prehistory Patient high anaemia risk ( e.g . Thalassaemia ) Retinopathy Severe illness Patients , follow study condition Male partner pregnant woman Current desire child / safe contraception therapy include 6 month study end Participation clinical study within last 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Opiate Dependence</keyword>
	<keyword>Chronic Hepatitis C</keyword>
</DOC>